CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands |
Dec. 31, 2019 |
Mar. 31, 2019 |
| Current assets: |
|
|
| Cash and cash equivalents |
$ 63,002
|
$ 25,704
|
| Short-term investments |
117,877
|
109,107
|
| Research and development incentives receivable |
4,775
|
2,474
|
| Prepaid expenses and other current assets |
5,220
|
3,696
|
| Total current assets |
190,874
|
140,981
|
| Property, plant and equipment, net |
5,654
|
12,159
|
| Restricted cash |
1,636
|
1,186
|
| Right-to-use asset - operating leases |
4,731
|
|
| Right-to-use asset - financing leases |
47,528
|
|
| Total assets |
250,423
|
154,326
|
| Current liabilities: |
|
|
| Accounts payable |
6,256
|
7,084
|
| Accrued expenses and other current liabilities |
4,557
|
2,801
|
| Operating lease liabilities, current |
1,011
|
|
| Financing lease liabilities, current |
2,393
|
|
| Total current liabilities |
14,217
|
9,885
|
| Deferred rent, net of current portion |
|
24
|
| Financing obligation |
|
6,561
|
| Long term debt, net of debt discount |
9,739
|
|
| Operating lease liabilities, non-current |
3,886
|
|
| Finance lease liabilities, non-current |
25,016
|
|
| Total liabilities |
52,858
|
16,470
|
| Commitments and contingencies (Note 12) |
|
|
| Stockholders' Equity: |
|
|
| Common stock, $0.001 par value; 150,000,000 shares authorized as of December 31, 2019 and March 31, 2019; 36,645,650 and 31,656,950 shares issued and outstanding as of December 31, 2019 and March 31, 2019 |
37
|
32
|
| Additional paid-in capital |
295,084
|
198,645
|
| Accumulated deficit |
(96,509)
|
(59,766)
|
| Accumulated other comprehensive loss |
(1,047)
|
(1,055)
|
| Total stockholders' equity |
197,565
|
137,856
|
| Total liabilities and stockholders' equity |
$ 250,423
|
$ 154,326
|